Calcium channel blocker, a derivative of 1,4-dihydropyridine, has a predominantly cerebrovasculative and antiischemic action. Prescribed for the prevention and treatment of brain ischemia on the background of subarachnoid hemorrhage caused by aneurysm rupture, expressed by brain disfunction in the elderly patients. It can prevent or eliminate spasm of vessels caused by various vasoconstrictor drugs. Improves stability and functional capacity of neurons.
Your order will be packed safe and secure and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has a size and a look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm) and it does not disclose its contents
Nimotop Product Description
Nimotop is a calcium channel blocking agent, which improves a process of delivering blood from small vessels to the brain tissues. Nimotop capsules are prescribed both for the treatment and for the prevention of episodes of neurologic dysfunction caused by ischemia.
The use of Nimotop capsules eliminates or prevents constriction of the brain capillaries caused by serotonin or other vasoactive compounds. This allows to eliminate consequences of hemorrhage after the brain aneurysm rupture in patients with Hunt and Hess (grade 1 to 5). For the improvement of neurological outcome, up to 360mg of Nimotop should be taken daily (two capsules of Nimotop 30 mg every 4 hours).
If you do not take Nimotop at the scheduled time, take this calcium channel blocker as soon as you remember. However, if it is time for the next dosage, do not take Nimotop at all. Then go back to your regular dosing schedule. Do not take Nimotop double dose and do not take extra medicine for the treatment of cerebrovascular disease to make up the missed dose.
The treatment should be initiated within 1 to 4 days after the ruptured brain aneurysm. The recommended duration of using Nimotop capsules is three weeks.
Nimotop, calcium channel blocker should be stored in its original packaging at room temperature not above 25°C. Nimotop tablets should be protected from bright light and freezing.
Nimotop Safety Information
Patients with traumatic brain injury and /or abnormal level of intracranial pressure should take Nimotop with caution, no more often than once every 4 hours. Patients with excessive accumulation of fluid within the brain tissue require additional monitoring.
All information about the treatment of ischaemic deficits stated in Nimotop review is created solely for informational purposes. This information is not intended to take the place of professional medical care by neurologists and other health care specialist. The online pharmacy does not accept any responsibility for any injury, which may occur due to improper use of the information about Nimotop calcium channel blocker.
Nimotop Side Effects
Nimotop causes adverse events are very rarely. The patients using Nimotop most often report about decreased blood pressure. Less than 1% of patients using Nimotop may experience headache, nausea, depression, allergic reactions (e.g. rash), shortness of breath, vasodilation, colonic bleeding, tachyarrhythmia, bradyarrhythmia, low platelet count or bronchial spasm.